药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Flurandrenolide
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Sitafloxacin.
Flurandrenolide
Oxatomide
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Oxatomide.
Flurandrenolide
Abexinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Abexinostat.
Flurandrenolide
Mizolastine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Mizolastine.
Flurandrenolide
Ricolinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ricolinostat.
Flurandrenolide
Simendan
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Simendan.
Flurandrenolide
CUDC-101
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with CUDC-101.
Flurandrenolide
Entinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Entinostat.
Flurandrenolide
Mocetinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Mocetinostat.
Flurandrenolide
Amifampridine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Amifampridine.
Flurandrenolide
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dexchlorpheniramine maleate.
Flurandrenolide
Benidipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Benidipine.
Flurandrenolide
Fendiline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Fendiline.
Flurandrenolide
Indenolol
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Indenolol.
Flurandrenolide
Bedaquiline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Bedaquiline.
Flurandrenolide
Antazoline
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Antazoline.
Flurandrenolide
Nilvadipine
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nilvadipine.
Flurandrenolide
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Nemonoxacin.
Flurandrenolide
Telavancin
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Telavancin.
Flurandrenolide
Tucidinostat
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Tucidinostat.